IR

Cellid Co.,Ltd. leads research of anti-cancer immunotherapies and Vaccines for preventing infectious diseases

Financial Information

80,000 60,000 40,000 20,000 0 -20,000
80,000 60,000 40,000 20,000 0 -20,000

20220

20230

2024 0

Total assets

80,000 60,000 40,000 20,000 0 -20,000

2022 0

2023 0

2024 0

Total liabilities

80,000 60,000 40,000 20,000 0 -20,000

2022 0

2023 0

2024 0

Total capitals

80,000 60,000 40,000 20,000 0 -20,000

2022 0

2023 0

2024 0

Operating profit

  • 2022
  • 2023
  • 2024

Balance sheet (unit : 1 million won)Scroll left and right to read.

Item 2022 2023 2024
Current Assets 0 0 0
Non-Current Assets 0 0 0
Total Assets 0 0 0
Current Liabilities 0 0 0
Non-Current Liabilities 0 0 0
Total Liabilities 0 0 0
Capital 0 0 0
Retained Earnings 0 0 0
Total Equity 0 0 0

Income statement (unit : 1 million won)Scroll left and right to read.

Item 2022 2023 2024